| |
|
|
|
Citius Pharmaceuticals Inc.  
|
|
0.57 -0 (-0%) |
10-16 15:58 |
|
Open: |
0.56 |
Pre close: |
0.5703 |
Target:
|
0.96 
|
|
High: |
0.6 |
Low: |
0.55 |
Resistance:
|
0.82
1.07
|
|
Volume: |
69,855 |
Market Cap: |
16M |
Support:
|
0.42
0.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.56
|
MACD |
MACD(12,26):
|
-0.11  |
|
MA(20): |
0.71 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
1.01 |
Stochastic Oscillator |
%K(14,3):
|
35.61 |
|
MA(250): |
1.13 |
%D(3): |
31.89 |
|
Average Volume(K) |
3-Month: |
16174
|
52-Week |
High:
|
1.79 |
|
10-Days: |
23945 |
Low: |
0.42 |
|
RSI |
RSI(14):
|
34.72 |
Change(%): |
-64.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.821 |
Return on Equity (ttm) |
-68.4 |
Shares Out. (M) |
28.84 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-39.5 |
Shares Float (M) |
12.31 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
43.10 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
4.20 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
177 |
|
Book Value (p.s.) |
0.970 |
EBITDA (p.s.) |
-0.541 |
P/E |
-0.69 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.59 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.04 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-7.04 |
P/CF |
-1.37 |
|
|
|
|
|
|
